Analysis of Iron Content in Food Supplements in Relation to the Safety of Their Use (original) (raw)

Abstract

The objective of the study was to test dietary supplements available on the European market with regard to their iron content. Twenty-nine vitamin and mineral supplements were investigated, with additional assessment of their mass homogeneity. Iron was determined by means of the AAS 1 method following microwave mineralization of particular samples. Findings were compared to iron contents declared by producers. Tested supplements were analyzed with regard to the ratio between the amount of iron supplied to the body and the RDA 2 for adults and pregnant women, as well as in view of the number of preparation pieces required to be taken in order to ensure the RDA in the groups included in the research. All preparations were characterised by high mass homogeneity. The iron content determined in the supplements was different from the values indicated by the producers on the packages. Four supplements did not meet the European requirements concerning acceptable limits of nutrient tolerance stated on the labels. Tolerance for iron value in food supplements indicated by producers on packages varied from RDAs for the studied groups. The dosage recommended by the producer was mostly different from the dosage necessary to meet the requirements for iron RDA in the studied groups.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (32)

  1. Andrews K.W., Roseland J.M, Gusev P.A., Palachuvattil J., Dang P.T., et al.: Am. J. Clin. Nutr. 105, 526 (2017).
  2. Value of the dietary supplements market in Europe in 2015 and 2020, by country. Statista (2018).
  3. Wierzejska R., Jarosz M., Siuba M., Rambu- szek M.: Rocz. Panstw. Zakl. Hig. 65, 317 (2014) (in Polish).
  4. Rocha T., Amaral J.S., Oliveira M.B.P.P.: CRFSFS 15, 43 (2016).
  5. Directive 2002/46/EC of the European Parlia- ment and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (2002).
  6. Sax J.K.: Am. J. Law Med. 41, 374 (2015).
  7. Szterk A., Zmys≥owski A., Bus K.: Food Chem. 243, 243 (2018).
  8. Akabas S.R., Vannice G., Atwater J.B., Cooper- man T., Cotter R., Thomas L.: J. Acad. Nutr. Diet. 116, 1370 (2016).
  9. Gozzelino R., Arosio P.: Int. J. Mol. Sci. 17, 130 (2016).
  10. Camaschella C.: N. Engl. J. Med. 372, 1832 (2015).
  11. Pasricha S.R., Low M., Thompson J., Farrell A., De-Regil L-M.: J. Nutr. 144, 906 (2014).
  12. Peyrin-Bisoulet L., Williet N., Cacoub P.: AJCN 102, 1585 (2015).
  13. Santiago P.: Sci. World J. 2012, 846 (2012).
  14. Guideline. Iron Supplementation in postpartum women. WHO, 2016.
  15. Mahmoud H.H., Muddathir A.M., Osman S.E.M., Alkhawad M.A., Awadia K.: Sudan. J. Public Health 9, 33 (2014).
  16. Abdalla S.E., Abdelgader E.A., Diab T.A., et al.: Merit Res. J. Microbiol. Biol. Sci. 1, 21 (2013).
  17. Radlowski E.C., Johnson R.W.: Front. Hum. Neurosci. 7, 1 (2013).
  18. Augusta de S• S., Willner E., Aguiar Duraes Pereira T., Rosse de Souza V., Teles Boaventura G., Blondet de Azeredo V.: Nutr. Hosp. 32, 2071 (2015)
  19. Bah A., Wegmuller R., Cerami C., Kendall L., Pasricha S.R.: et al.: BMC Pregnancy Childbirth 16, 157 (2016).
  20. Picciano M.F., McGuire M.K.: Am. J. Clin. Nutr. 89, 663 (2009).
  21. Wong L., Smith S., Gilstrop M., Derman R., Auerbach S., et al.: Am. J. Hematol. 91, 590 (2016).
  22. Cantor A.G., Bougatsos C., Dana T., Blazina I., McDonagh M.: Ann. Intern. Med. 162, 566 (2015).
  23. Abbaspour N., Hurrell R., Kelishadi R.: J. Res. Med. Sci. 19, 164 (2014).
  24. Krawczyk M.: J. Pharm. Biomed. Anal. 88, 377 (2014).
  25. Guidance document for competent authorities for the control of compliance with EU legisla- tion. European Commission (2012).
  26. Panel on Micronutrients. Washington (DC): National Academies Press (US); Dietary Refe- rence Intakes for Vitamin A, Vitamin K, Arse- nic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Institute of Medicine (2001)
  27. Qato D.M., Wilder J., Schumm L.P., Gillet V., Alexander G.C.: JAMA Intern. Med. 176, 473 (2016).
  28. Bishnoi V.K., Yadav P.: IJARCSMS 5, 65 (2017).
  29. Pawlak A., Rajczykowski K., Loska K., Ahnert B., Wiechu≥a D.: Bromat. Chem. Toxycol. 49, 23 (2016).
  30. Milman N., Taylor C.L., Merkel J., Brannon P.M.: Am. J. Clin. Nutr. 106, 1655S (2017).
  31. Committee for Medicinal Products for Human Use. Guideline on the chemistry of active sub- stances. European Medicines Agency (2016).
  32. © 2020 by Polish Pharmaceutical Society. This is an open-access article under the CC BY NC license (http://creativecommons.org/licenses/by-nc/4.0/).